Home › Breckenridge Announces Approval Of Rizatriptan Benzoate Tablets
 

Keywords :   


Breckenridge Announces Approval Of Rizatriptan Benzoate Tablets

2013-01-02 01:42:40| drugdiscoveryonline News Articles

Breckenridge Pharmaceutical, Inc.announced today the immediate launch of Rizatriptan Benzoate Tablets. The U.S. Food and Drug Administration granted finalapproval for the Abbreviated New Drug Application (ANDA) for this product, which is being manufactured and supplied by Natco Pharma Limited, and will be available in both 5mg and 10mg strengths

Tags: approval announces tablets breckenridge

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
14.06Boeing plane investigated after 'Dutch roll'
14.06Atlantic Tropical Weather Outlook
14.06Eastern North Pacific Tropical Weather Outlook
14.06Supermarket sandwiches linked to E. coli outbreak
14.06Barclays suspends festival funding after protests
14.06 OQ Chemicals Announces Price Increases for Carboxylic Acids
14.06PNWSCT CoatingsFest 24 Golf Tees Off Sept. 11
14.06BMG is Exclusive Distributor for Marabu Coatings in the US
More »